Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Craig Miller

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancerUgo De Giorgi, Vicente Valero, Eric Rohren, et al.
Cancer Research|June 17, 2005
Global gene expression profiling of circulating tumor cellsDenis A Smirnov, Daniel R Zweitzig, Bradley W Foulk, et al.
Journal of Circulating Biomarkers|August 21, 2023
Analytical performance of the FDA-cleared Parsortix<sup>®</sup> PC1 systemAmy Templeman, M Craig Miller, Martin J Cooke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancerSteven J Cohen, Cornelis J A Punt, Nicholas Iannotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2014
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancerCostanza Paoletti, Maria C Muñiz, Dafydd G Thomas, et al.
Brain : a Journal of Neurology|January 21, 2026
Plasma pTau 217:β-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathologyNatalya Benina, Luna Buitrago, Francesca I De Simone, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 8, 2026
Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's diseaseAbhay R Moghekar, James A Rock, Richard C Mohs, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancerUgo De Giorgi, Vicente Valero, Eric Rohren, et al.
Cancer Research|June 17, 2005
Global gene expression profiling of circulating tumor cellsDenis A Smirnov, Daniel R Zweitzig, Bradley W Foulk, et al.
Journal of Circulating Biomarkers|August 21, 2023
Analytical performance of the FDA-cleared Parsortix<sup>®</sup> PC1 systemAmy Templeman, M Craig Miller, Martin J Cooke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancerSteven J Cohen, Cornelis J A Punt, Nicholas Iannotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2014
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancerCostanza Paoletti, Maria C Muñiz, Dafydd G Thomas, et al.
Brain : a Journal of Neurology|January 21, 2026
Plasma pTau 217:β-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathologyNatalya Benina, Luna Buitrago, Francesca I De Simone, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 8, 2026
Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's diseaseAbhay R Moghekar, James A Rock, Richard C Mohs, et al.
Pageof 6